Spironolactone
Product Images NDC 53002-2707

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53002-2707). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530022707)

Label Image (Lbl530022707)
Packaging label for Spironolactone 50 mg tablets by RPK Pharmaceuticals, Inc. The label indicates 30 tablets per package and includes instructions to take the tablets a specified number of times per day. The label features dosage, manufacturer information, lot number, expiration date, and space for prescribing and patient details.*
FDA Label Image

Figure 1 (Spironolactone Figure 1)

Figure 1 (Spironolactone Figure 1)
A Kaplan-Meier survival curve showing probability over months comparing Spironolactone (n=822) versus Placebo (n=841). The chart depicts a higher survival probability for Spironolactone over a period of up to 48 months, with a log-rank p-value less than 0.001 indicating statistical significance.*
FDA Label Image

Figure 2 (Spironolactone Figure 2)

Figure 2 (Spironolactone Figure 2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups comparing Spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The number of subjects (N) and percentage (%) in each subgroup are listed. The plot visually compares outcomes favoring Spironolactone or placebo.*
FDA Label Image

Chemical Structure (Spironolactone Structure Image)

Chemical Structure (Spironolactone Structure Image)
Chemical structure of spironolactone, illustrating its steroidal core with attached functional groups, including the lactone ring and thioacetate group as shown in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.